Today(7th May): The Supreme Court ruled that celebrities and influencers are equally responsible for endorsing misleading advertisements. They emphasized the need for transparency in paid endorsements and stated that endorsers, advertisers, and advertising agencies share equal responsibility. The Court issued directions to promote accountability, including the submission of self-declaration forms by advertisers and TV broadcasters.
Today(on May 7th), Supreme Court addresses Patanjali’s misleading online ads, emphasizes accountability and consumer protection. Demands action and plan from Patanjali while stressing suspension of sales for products with revoked licenses.
The Managing Director of Patanjali Ayurveda, Acharya Balkrishna, filed a plea against the President of the Indian Medical Association (IMA), Dr. RV Asokan, for disparaging remarks about the Supreme Court. This arises from the Court’s criticism of IMA’s unethical practices. Simultaneously, the Supreme Court is hearing a petition by IMA against Patanjali Ayurveda for misleading advertisements.
The Supreme Court Today (April 30th) took strong exception to comments made by Indian Medical Association (IMA) President Dr RV Asokan against the top court in relation to the Patanjali misleading ads case.
Today (30th April): The Supreme Court rebuked the Uttarakhand State Licensing Authority for inaction in a case involving misleading advertisements by Patanjali Ayurveda. The court criticized Patanjali for non-compliance with its orders but appreciated the improvement in their actions after issuing a public apology. The court highlighted the need for caution and responsible advertising practices.
On Monday(29th April),The Uttarakhand licensing authority suspended licenses for 14 Patanjali Divya Pharmacy products due to misleading ads. The Supreme Court will address Ramdev and Acharya Balkrishna’s published apology today(on April 30th).
Today (29th April): The Supreme Court questioned the feasibility of imposing uniform rates on private hospitals, emphasizing market forces’ role in pricing. This arose in response to a petition challenging regulations on uniform rates for ophthalmological procedures. Disappointment was expressed over private hospitals’ failure to reserve beds for economically weaker sections, and concerns were raised about government regulations.
Today (23rd April):The Supreme Court criticized the Indian Medical Association (IMA) for prescribing expensive and unnecessary medicines, urging the IMA to rectify its internal issues and uphold ethical standards. The court emphasized close scrutiny of cases where the IMA endorses costly treatments and directed licensing authorities and the IMA to be involved in a case addressing misleading health claims.
Ramdev-Patanjali Ayurved, Today (April 23rd) during a hearing in the Supreme Court over the misleading ads, said it had published an apology in 67 newspapers, asserting it had the utmost respect for the court and their mistakes would not be repeated. Court asked if the size of the apology put out in newspapers by Patanjali was similar to full-page advertisements for its products.
Hours ahead of a Supreme Court hearing Today (April 23rd) in the misleading ads case against it, Patanjali Ayurved today put out an apology in a national daily, stressing that they have utmost respect for the court and that their mistakes will not be repeated.
